APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Liraglutide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liraglutide Drugs Market Analysis and Forecast 2026-2032

Report ID 17400822022 January 2026191 pages

Choose your research edition.

Industry ResearchLiraglutide Drugs Industry Research Report 2026104 pages · $2,950 USDIndustry Growth & TrendsGlobal Liraglutide Drugs Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Liraglutide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liraglutide Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Liraglutide Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Liraglutide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Liraglutide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liraglutide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liraglutide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liraglutide Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Liraglutide Drugs include Novo Nordisk and Viatris etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Liraglutide Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liraglutide Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Liraglutide Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liraglutide Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liraglutide Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liraglutide Drugs revenue, projected growth trends, production technology, application and end-user industry.

Liraglutide Drugs Segment by Company

Novo Nordisk

Viatris

Liraglutide Drugs Segment by Type

Victoza

Saxenda

Liraglutide Drugs Segment by Application

Type 2 Diabetes

Obesity

Liraglutide Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liraglutide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liraglutide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liraglutide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liraglutide Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liraglutide Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liraglutide Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liraglutide Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Victoza Major Player Table 3. Saxenda Major Player Table 4. Global Liraglutide Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Type 2 Diabetes Major Player Table 6. Obesity Major Player Table 7. Liraglutide Drugs Industry Trends Table 8. Liraglutide Drugs Industry Drivers Table 9. Liraglutide Drugs Industry Opportunities and Challenges Table 10. Liraglutide Drugs Industry Restraints Table 11. Global Liraglutide Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Liraglutide Drugs Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Liraglutide Drugs Market Share by Region (2021-2026) Table 14. Global Liraglutide Drugs Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Liraglutide Drugs Market Share by Region (2027-2032) Table 16. Global Liraglutide Drugs Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Liraglutide Drugs Revenue Market Share by Players (2021-2026) Table 18. Global Liraglutide Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Liraglutide Drugs Key Players Headquarters & Area Served Table 20. Global Liraglutide Drugs Players, Product Type & Application Table 21. Global Liraglutide Drugs Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Liraglutide Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Liraglutide Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Liraglutide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Liraglutide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Liraglutide Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Liraglutide Drugs Revenue Market Share by Type (2027-2032) Table 29. Global Liraglutide Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Liraglutide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Liraglutide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Liraglutide Drugs Revenue Market Share by Application (2021-2026) Table 33. Global Liraglutide Drugs Revenue Market Share by Application (2027-2032) Table 34. Novo Nordisk Company Information Table 35. Novo Nordisk Business Overview Table 36. Novo Nordisk Liraglutide Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Novo Nordisk Liraglutide Drugs Product Portfolio Table 38. Novo Nordisk Recent Development Table 39. Viatris Company Information Table 40. Viatris Business Overview Table 41. Viatris Liraglutide Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Viatris Liraglutide Drugs Product Portfolio Table 43. Viatris Recent Development Table 44. North America Liraglutide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 45. North America Liraglutide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 46. North America Liraglutide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. North America Liraglutide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. North America Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 49. North America Liraglutide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 50. North America Liraglutide Drugs Revenue by Country (US$ Million) & (2027-2032) Table 51. Europe Liraglutide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 52. Europe Liraglutide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 53. Europe Liraglutide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 54. Europe Liraglutide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 55. Europe Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Europe Liraglutide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 57. Europe Liraglutide Drugs Revenue by Country (US$ Million) & (2027-2032) Table 58. China Liraglutide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 59. China Liraglutide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 60. China Liraglutide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 61. China Liraglutide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 62. Asia Liraglutide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 63. Asia Liraglutide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 64. Asia Liraglutide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 65. Asia Liraglutide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 66. Asia Liraglutide Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 67. Asia Liraglutide Drugs Revenue by Region (US$ Million) & (2021-2026) Table 68. Asia Liraglutide Drugs Revenue by Region (US$ Million) & (2027-2032) Table 69. SAMEA Liraglutide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 70. SAMEA Liraglutide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 71. SAMEA Liraglutide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 72. SAMEA Liraglutide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 73. SAMEA Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. SAMEA Liraglutide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 75. SAMEA Liraglutide Drugs Revenue by Country (US$ Million) & (2027-2032) Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Liraglutide Drugs Image Figure 2. Global Liraglutide Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liraglutide Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Victoza Image Figure 5. Saxenda Image Figure 6. Global Liraglutide Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liraglutide Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Type 2 Diabetes Image Figure 9. Obesity Image Figure 10. Global Liraglutide Drugs Market Size (US$ Million) & (2021-2032) Figure 11. Global Liraglutide Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Liraglutide Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Liraglutide Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Liraglutide Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Liraglutide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Liraglutide Drugs Revenue Market Share by Type (2021-2032) Figure 18. Global Liraglutide Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Liraglutide Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Liraglutide Drugs Revenue Market Share by Application (2021-2032) Figure 21. North America Liraglutide Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Liraglutide Drugs Revenue Share by Type (2021-2032) Figure 23. North America Liraglutide Drugs Revenue Share by Application (2021-2032) Figure 24. North America Liraglutide Drugs Revenue Share by Country (2021-2032) Figure 25. United States Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Liraglutide Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Liraglutide Drugs Revenue Share by Type (2021-2032) Figure 30. Europe Liraglutide Drugs Revenue Share by Application (2021-2032) Figure 31. Europe Liraglutide Drugs Revenue Share by Country (2021-2032) Figure 32. Germany Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Liraglutide Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Liraglutide Drugs Revenue Share by Type (2021-2032) Figure 42. China Liraglutide Drugs Revenue Share by Application (2021-2032) Figure 43. Asia Liraglutide Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Liraglutide Drugs Revenue Share by Type (2021-2032) Figure 45. Asia Liraglutide Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Liraglutide Drugs Revenue Share by Region (2021-2032) Figure 47. Japan Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Liraglutide Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Liraglutide Drugs Revenue Share by Type (2021-2032) Figure 55. SAMEA Liraglutide Drugs Revenue Share by Application (2021-2032) Figure 56. SAMEA Liraglutide Drugs Revenue Share by Country (2021-2032) Figure 57. Brazil Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Liraglutide Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Victoza
  • Saxenda
Applications
  • Type 2 Diabetes
  • Obesity
Companies covered
  • Novo Nordisk
  • Viatris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liraglutide Drugs Market by Type
  3. 1.2.1 Global Liraglutide Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Victoza
  5. 1.2.3 Saxenda
  6. 1.3 Liraglutide Drugs Market by Application
  7. 1.3.1 Global Liraglutide Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Type 2 Diabetes
  9. 1.3.3 Obesity
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Liraglutide Drugs Market Dynamics
  1. 2.1 Liraglutide Drugs Industry Trends
  2. 2.2 Liraglutide Drugs Industry Drivers
  3. 2.3 Liraglutide Drugs Industry Opportunities and Challenges
  4. 2.4 Liraglutide Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liraglutide Drugs Market Perspective (2021-2032)
  2. 3.2 Global Liraglutide Drugs Growth Trends by Region
  3. 3.2.1 Global Liraglutide Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liraglutide Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Liraglutide Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liraglutide Drugs Revenue by Players
  2. 4.1.1 Global Liraglutide Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Liraglutide Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liraglutide Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liraglutide Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liraglutide Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Liraglutide Drugs Players, Product Type & Application
  8. 4.5 Global Liraglutide Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liraglutide Drugs Market CR5 and HHI
  11. 4.6.3 2025 Liraglutide Drugs Tier 1, Tier 2, and Tier 3
5 Liraglutide Drugs Market Size by Type
  1. 5.1 Global Liraglutide Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liraglutide Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Liraglutide Drugs Revenue Market Share by Type (2021-2032)
6 Liraglutide Drugs Market Size by Application
  1. 6.1 Global Liraglutide Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liraglutide Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Liraglutide Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novo Nordisk
  2. 7.1.1 Novo Nordisk Company Information
  3. 7.1.2 Novo Nordisk Business Overview
  4. 7.1.3 Novo Nordisk Liraglutide Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk Liraglutide Drugs Product Portfolio
  6. 7.1.5 Novo Nordisk Recent Developments
  7. 7.2 Viatris
  8. 7.2.1 Viatris Company Information
  9. 7.2.2 Viatris Business Overview
  10. 7.2.3 Viatris Liraglutide Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Viatris Liraglutide Drugs Product Portfolio
  12. 7.2.5 Viatris Recent Developments
8 North America
  1. 8.1 North America Liraglutide Drugs Revenue (2021-2032)
  2. 8.2 North America Liraglutide Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Liraglutide Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Liraglutide Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Liraglutide Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Liraglutide Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Liraglutide Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Liraglutide Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Liraglutide Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Liraglutide Drugs Revenue by Country
  11. 8.6.1 North America Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liraglutide Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Liraglutide Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Liraglutide Drugs Revenue (2021-2032)
  2. 9.2 Europe Liraglutide Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liraglutide Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liraglutide Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Liraglutide Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liraglutide Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liraglutide Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liraglutide Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Liraglutide Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liraglutide Drugs Revenue by Country
  11. 9.6.1 Europe Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liraglutide Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liraglutide Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Liraglutide Drugs Revenue (2021-2032)
  2. 10.2 China Liraglutide Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Liraglutide Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Liraglutide Drugs Revenue by Type (2027-2032)
  5. 10.3 China Liraglutide Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Liraglutide Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Liraglutide Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Liraglutide Drugs Revenue by Application (2027-2032)
  9. 10.5 China Liraglutide Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liraglutide Drugs Revenue (2021-2032)
  2. 11.2 Asia Liraglutide Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liraglutide Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liraglutide Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Liraglutide Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liraglutide Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liraglutide Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liraglutide Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Liraglutide Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liraglutide Drugs Revenue by Country
  11. 11.6.1 Asia Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liraglutide Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liraglutide Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liraglutide Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Liraglutide Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liraglutide Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liraglutide Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liraglutide Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liraglutide Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liraglutide Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liraglutide Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liraglutide Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liraglutide Drugs Revenue by Country
  11. 12.6.1 SAMEA Liraglutide Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liraglutide Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liraglutide Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst